Tempus AI IPO: AI in Diagnostics at Scale, Investor Sentiment Appears Positive
Healthcare IT company Tempus AI is expected to IPO next week, making it one of several high-profile AI unicorns scheduled to go public this year.
GRAIL: Detecting Early-Stage Cancers With Galleri Test, A Significant Market Opportunity
GRAIL, a fast-growing Galleri test maker, spun off from Illumina in June. The population-scale MCED screening test identifies 50+ types of cancer...
No more insights